Pain relief and persistence of dysautonomic features in a patient with hemicrania continua responsive to botulinum toxin type A

Cephalalgia. 2010 Apr;30(4):500-3. doi: 10.1111/j.1468-2982.2009.01918.x. Epub 2010 Feb 1.

Authors

I Garza¹, F M Cutrer

Affiliation

¹ Mayo Clinic Department of Neurology, Rochester, MN 55905, USA. garza.ivan@mayo.edu

PMID: 19515122
DOI: 10.1111/j.1468-2982.2009.01918.x

No abstract available

Publication types

Case Reports

MeSH terms

Botulinum Toxins, Type A / administration & dosage*
Headache Disorders, Primary / drug therapy*
Headache Disorders, Primary / physiopathology
Humans
Male
Middle Aged
Neuromuscular Agents / therapeutic use*
Primary Dysautonomias / drug therapy*
Primary Dysautonomias / physiopathology
Treatment Outcome

Substances

Neuromuscular Agents
Botulinum Toxins, Type A